The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cervical cancer diagnostics market report forecasts the cervical cancer diagnostics market size to grow to $11.03 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Cervical Cancer Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

Cervical Cancer Diagnostics Market Size Forecast
The global cervical cancer diagnostics market is expected to grow from $8.29 billion in 2022 to $8.86 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cervical cancer diagnostics market is expected to grow from $11.03 billion in 2027 at a CAGR of 5.6%.

North America held the largest cervical cancer diagnostics market share.

Key Cervical Cancer Diagnostics Market Driver ­– Rise In Adoption Of Cervical Cancer Diagnostic Tests For The Early Detection Of Cervical Cancer
For instance, in August 2020, the World Health Assembly adopted a global strategy to accept cervical cancer as a global challenge and to develop a global strategy to eliminate cervical cancer. First step of this strategy is promoting diagnosis. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the market.

Request for A Sample Of The Global Cervical Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3285&type=smp

Key Cervical Cancer Diagnostics Market Trend – Adopting HPV Home Testing Kits
The increased adoption of HPV home testing kits is expected to be the new trend in the market. The home-based HPV testing kits help women in collecting samples and getting the results conveniently on their own without going to the lab for screening. Therefore, companies are focusing on providing convenience to patients. For instance, in September 2022, Mylab Discovery Solutions launched the ‘PathoDetectTM HPV PCR detection Kit (Type 16/18). The new product is a home testing kit for detection of HPV type 16 and type 18.

Cervical Cancer Diagnostics Market Segment
1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy, and Endocervical Curettage, Other Diagnostic Tests
2) By End User: Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres, Diagnostic Centres
3) By Age Group: Below 21, Age between 21 to 29, Age between 30 to 65, Above 65

Cervical Cancer Diagnostics Market Major Players and Strategies
Major players in the cervical cancer diagnostics market are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, ZiliCo., and Guided Therapeutics.

In May 2020, the USA-based firm, Becton, Dickinson & Co., a manufacturer and seller of medical devices, instrument systems, and reagents, announced the acquisition of San Diego biomedical business CareFusion for $12.2 billion. The acquisition is expected to improve the quality of patient care and reduce health care costs by identifying the needs in hospitals, hospital pharmacies, and alternate sites of care.

The Cervical Cancer Diagnostics Global Market Report 2023 covers regional data on cervical cancer diagnostics market size, cervical cancer diagnostics market trends and drivers, opportunities, strategies, and cervical cancer diagnostics market competitor analysis. The countries covered in the cervical cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cervical cancer is a type of squamous cell carcinoma that occurs in the cervix (the lower part of the uterus). The cervix cancer diagnostic devices are used to diagnose cancer that occurs in the cervix.

View More Reports Related To The Cervical Cancer Diagnostics Market –
Cervical Cancer Drugs Global Market Report 2023
HPV Associated Disorders Global Market Report 2023
Community Oncology Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: